| LIVANOVA PLC DL -,01 |
| Großbritannien |
| Gesundheit |
| GB00BYMT0J19 / A14156 |
| LIA (Frankfurt) / LIVN (NASDAQ) |
| FRA:LIA, ETR:LIA, LIA:GR, NASDAQ:LIVN |
| - |
| https://www.livanova.com/ |
|
LivaNova is a global medical technology company that develops innovative devices and therapies for cardiac surgery, cardiopulmonary support, and neuromodulation treatments. The company's primary product portfolio includes vagus nerve stimulation ther..
>Volltext.. |
| 2846.37 Mio. EUR |
| 2674.41 Mio. EUR |
| 1184.28 Mio. EUR |
| -82.31 Mio. EUR |
| -206.89 Mio. EUR |
| -3.81 EUR |
| 370.1 Mio. EUR |
| 542.26 Mio. EUR |
| 217 Mio. EUR |
| 0.79 |
| -2.1% |
| -437.95% |
| - |
| - |
| - |
| - |
| LIVANOVA |
| 06.05.26 |
|
||||
|
||||
|